Objective To investigate the association between visceral fat area (VFA) and metabolic syndrome (Mets) among normal weight Japanese.
Design A cross-sectional study.
Setting The health check-up centre of the Takeda Hospital group in Kyoto, Japan.
Methods This study involved 1674 men and 1448 women aged 30–74 years who underwent medical check-ups in 2012 in the health check-up centre. They were stratified by Body Mass Index (BMI cut-off for obesity is set at 23.0 kg/m2 for Asians): normal weight 18.5–22.9 kg/m2 or higher weight ≥23.0 kg/m2. The age-adjusted ORs of the 2nd to 4th groups of sex-specific VFA quartiles compared with the 1st quartile for a Mets component clustering were estimated. The clustering was having two or more of the following factors: high blood pressure, high fasting blood glucose (FBG), low high-density lipoprotein cholesterol (HDL-C) and high triglycerides. Statistical analyses were conducted in 2016.
Results Participants in the 2nd to 4th VFA quartiles had significantly higher clustering risks; ORs were 3.4 (1.5 to 8.0), 6.3 (2.8 to 14.2) and 9.3 (4.2 to 20.7) for normal weight participants, and 1.7 (1.2 to 2.6), 2.6 (1.8 to 3.9) and 6.0 (4.1 to 8.8) for higher weight participants, respectively. The ORs of the 4th VFA quartile for Mets components were significantly higher; ORs for normal weight participants were 2.1 (1.5 to 3.0) (high blood pressure), 2.4 (1.4 to 4.2) (high FBG), 5.2 (2.1 to 12.9) (low HDL-C) and 12.0 (5.7 to 25.3) (high triglycerides), and higher weight participants were 3.9 (2.8 to 5.5), 4.1 (2.8 to 6.2), 3.9 (2.2 to 6.9) and 5.0 (3.4 to 7.4), respectively.
Conclusions Among participants with normal weight, as well as those of higher weight, dose-dependent responses were observed between VFA and risk for Mets components and the clustering among Japanese adults. VFA may be useful information for interventions to improve metabolic risk factors in people with normal weight.
- DIABETES & ENDOCRINOLOGY
- PUBLIC HEALTH
- visceral fat
This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Strengths and limitation of this study
This is the first study highlighting the associations between visceral fat area and metabolic syndrome among normal weight Asians (Body Mass Index 18.5–22.9 kg/m2).
There is the potential for a selection bias as this study involved the participants with relatively high health awareness who voluntarily underwent comprehensive medical check-ups.
There are potential limitations for a cross-sectional design which could not clarify causal associations.
Obesity, characterised as excessive body fat, is a risk factor for metabolic and cardiovascular diseases. For the purposes of preventing and predicting these diseases, anthropometric measurements are used as screening for obesity at health check-ups. Of several anthropometric measurements, Body Mass Index (BMI) is used to assess generalised obesity because it correlates highly with the percentage of body fat.1 Cut-off points for BMI are defined by the WHO; a BMI of 18.5–24.9 kg/m2 is considered normal weight.2 For Asians, the WHO decreased the upper cut-off point to a BMI of 23.0 kg/m2 because Asians have higher percentages of body fat for the same age, sex and BMI compared with Caucasians and have a higher prevalence of metabolic diseases among those even below a BMI of 25.0 kg/m2.2 However, it is undeniable that fat accumulation is associated with metabolic and cardiovascular diseases even among normal weight individuals with BMIs 18.5–22.9 kg/m2 because BMI is related to fat-free mass and does not directly represent fat accumulation.1
In recent years, attention has been given to reports that people who have normal weight defined by BMI but high levels of body fat or a high waist-to-hip ratio, normal weight central obesity, also have high risk for metabolic and cardiovascular diseases.3 ,4 These reports may indicate that body fat accumulation especially in the abdominal area is a key component for these diseases among normal weight people. In studies measuring the abdominal fat area,5–18 some studies investigated the associations between the visceral fat area (VFA) and metabolic syndrome (Mets) components among normal weight people with a BMI<25.0 kg/m2.7 ,8 ,12 ,13 However, although the association between VFA and lipid profile has been investigated, the associations with blood pressure (BP), blood glucose and Mets component clustering have not yet been investigated among normal weight Asians as defined by the WHO (BMI 18.5–22.9 kg/m2).7 ,12
Therefore, we investigated the risk of high VFA for Mets components and the clustering of these components in Japanese adults with BMIs 18.5–22.9 kg/m2 to clarify whether visceral fat accumulation is associated with Mets. If there is a significant association, VFA may be useful information to find targets to improve Mets among normal weight individuals.
Research design and methods
The present cross-sectional study included 3622 individuals who underwent a comprehensive medical check-up at Takeda Hospital Group in 2012. Of these, 500 were excluded for the following reasons: (1) age <30 or >75 years (n=165), (2) BMI<18.5 kg/m2 (n=246) and (3) missing data (n=79). The remaining 3122 participants were included in the analysis (figure 1). Written informed consent was obtained from all participants prior to the start of the study.
Participants completed a questionnaire involving demographic information, medical history, smoking (current, quit or never) and drinking habits (current, quit or never), exercise habits (with frequency and time) and eating behaviours. Participants were measured for height and weight with light clothing. BMI was calculated as weight (kg) divided by height squared (m2). VFA was measured in the morning before breakfast by dual bioelectrical impedance analysis which is the first device in the world for measuring visceral fat without X-ray exposure (DUALSCAN; Omron Healthcare Co., Kyoto, Japan).19–21 BP was measured using a sphygmomanometer after 5 min of rest. Blood tests were conducted in the morning following an overnight fast. All measurements were carried out in the clinical laboratory of the Takeda Hospital Group. Blood glucose, high-density lipoprotein cholesterol (HDL-C) and triglyceride (TG) concentrations were measured by enzymatic methods.
The Mets components used as outcomes in the present study were high BP, high fasting blood glucose (FBG), low HDL-C and high TG. High BP was defined as systolic BP≥130 mm Hg and/or diastolic BP≥85 mm Hg and/or the use of antihypertensive agents. High FBG was defined as FBG≥5.55 mmol/L and/or use of antidiabetic agents. Low HDL-C was defined as HDL-C<1.29 mmol/L (women) or 1.03 mmol/L (men). High TGs were defined as TGs≥1.69 mmol/L. These definitions were based on the uniform definition proposed in the 2009 joint international statement.22 Furthermore, Mets component clustering was defined as having two or more of the above four Mets components.
Sex-specific analyses were performed because VFA distributions differ by sex. Sex differences in characteristics were defined by Student's t-test for normally distributed continuous variables, Mann-Whitney U test for skewed continuous variables, and χ2 test for categorical and dichotomous variables. The normality of continuous variables was determined by the one-sample Kolmogorov-Smirnov test. Although all continuous variables were normally distributed (p<0.001 in all variables), TGs were analysed using the Mann-Whitney U test because TG data visually had a log-normal distribution.
Participants were stratified into two BMI groups by the WHO Asian specific criteria: a normal weight group (BMI 18.5–22.9 kg/m2) and a higher weight group (BMI≥23.0 kg/m2).2 ,23 Participants were further classified using VFA quartiles by sex and BMI strata (normal weight: q1, q2, q3 and q4; higher weight: Q1, Q2, Q3 and Q4) (figure 1). Percentages of participants having Mets components according to BMI strata and VFA quartiles were calculated. Logistic regression analysis was used to estimate age-adjusted ORs and 95% CIs for each Mets component and the clustering among participants in the 2nd, 3rd and 4th quartiles as compared with the 1st quartile by BMI strata. The same analyses were conducted among participants without liver or renal disease, thyroid disease, tumours or psychiatric diseases to confirm the associations and to eliminate the potential bias caused by these diseases. Furthermore, stratifying by age (30–64 years or 65–74 years) and BMI (18.5–22.9 kg/m2 or ≥23.0 kg/m2), participants were recategorised according to sex-specific VFA quartiles and ORs were estimated. Interactions between age and VFA for Mets component clustering in each BMI strata were tested.
Finally, to clarify the association between improvable lifestyle factors and VFA among normal weight, the differences of VFA according to lifestyle factors were assessed using analysis of covariance. The dependent variable was VFA and the independent variables were age and the following lifestyle factors: drinking habits (current, quit or never), smoking habits (current, quit or never), exercise habits (0, 1–59 or 60 or more min/week),24 eating until full (yes, no) and eating quickly (yes, no).25 Owing to the small sample size of ex-drinkers (men, n=24; women, n=15), these participants were combined with the never drinkers. Multiple comparisons for smoking and exercise habits were conducted using the Bonferroni method. In addition, multiple stepwise regression analyses (the significance level was 0.05 for entry and 0.1 to remain) were conducted to confirm the independent factors associated with VFA. All reported p values were two tailed and those <0.05 were considered statistically significant. All data were analysed using SPSS, V.22.0J (Japan IBM, Tokyo, Japan) and Stata, V.14.1 (IBM Corp., Armonk, New York, USA) in 2016.
Characteristics of participants
The characteristics of participants are shown in table 1. The mean age was 51.2 years in men and 49.8 years in women. Means of BMI, BP, TG and FBG were significantly higher in men than in women. Mean levels of HDL-C were significantly higher in women than in men. Lifestyles characteristics, except for eating until full, were different by sex. Among those with a BMI of 18.5–22.9 kg/m2, there were 745 men (mean BMI=21.3±1.1) and 1033 women (mean BMI=20.6±1.3). Of those with a BMI≥23.0 kg/m2, there were 929 men (mean BMI=25.7±2.5) and 415 women (mean BMI=25.8±2.7).
VFA and Mets
The percentages of participants having Mets components according to BMI and VFA are shown in table 2. Among men, the 25th, 50th and 75th centile values of VFA (cm2) were 43.7, 56.6 and 71.6 in the normal weight group, and 70.7, 88.3 and 109.3 in the higher weight group. Among women, the values were 28.6, 39.1 and 50.5 in the normal weight group, and 48.1, 67.0 and 86.4 in the higher weight group. Since, some groups had small numbers of cases and the percentages of all metabolic risk factors basically increased with a rise in VFA in both sexes, logistic regression analyses were performed without stratification by sex. The age-adjusted ORs for Mets components and the clustering according to VFA quartiles in all participants are shown in figure 2. Dose-dependent responses between VFA and all Mets components and the clustering were observed (all p for trend <0.01). The details of ORs and 95% CIs are shown in online supplementary table S1. The ORs for the Mets component clustering were significantly higher in the 2nd, 3rd and 4th quartile groups. The ORs (95% CIs) were 3.42 (1.46 to 8.04), 6.29 (2.79 to 14.17) and 9.35 (4.22 to 20.68) in q2, q3 and q4 (BMI 18.5–22.9 kg/m2 group), respectively, and 1.73 (1.16 to 2.58), 2.64 (1.79 to 3.88) and 6.00 (4.12 to 8.76) in Q2, Q3 and Q4 (BMI≥23.0 kg/m2 group), respectively. Although the 2nd quartile did not have a significantly high risk for all Mets components, the 3rd and 4th quartiles had a significantly high risk for all Mets components. The ORs of the 4th quartile for high BP, high FBG, low HDL-C and high TG were 2.12 (1.49 to 3.02), 2.42 (1.39 to 4.24), 5.23 (2.11 to 12.94) and 12.00 (5.69 to 25.31), respectively, in the normal weight group, and 3.90 (2.77 to 5.48), 4.13 (2.77 to 6.17), 3.93 (2.23 to 6.93) and 4.97 (3.37 to 7.35), respectively, in the higher weight group. These results did not change after excluding participants with liver or renal disease, thyroid disease, tumours or psychiatric disease (see online supplementary table S2 and figure S1). Additionally, because the definition of Mets based on the 2009 joint international statement does not include medical treatment of hypercholesterolaemia, the ORs for the clustering and low HDL-C adjusted for age and medical treatment of hypercholesterolaemia were estimated. As a result, the ORs did not change much. The ORs (95% CIs) for the clustering were 3.31 (1.41 to 7.79), 6.11 (2.71 to 13.76) and 8.72 (3.93 to 19.35) in q2, q3 and q4, respectively, and 1.70 (1.14 to 2.55), 2.61 (1.77 to 3.85) and 5.94 (4.06 to 8.69) in Q2, Q3 and Q4, respectively. The ORs for low HDL-C were 0.82 (0.25 to 2.71), 3.64 (1.45 to 9.14) and 5.06 (2.03 to 12.58) in q2, q3 and q4, respectively, and 2.09 (1.15 to 3.79), 2.84 (1.59 to 5.08) and 3.92 (2.22 to 6.90) in Q2, Q3 and Q4, respectively.
VFA and Mets by age
Of participants aged 30–64 years, 1620 were of normal weight and 1208 were of higher weight. Of those aged 65–74 years, 158 were of normal weight and 136 were of higher weight. The percentages and ORs of Mets in each age and BMI strata are shown in online supplementary table S3 and figure S2.
In the normal weight group, the ORs for the Mets component clustering were significantly higher in the 2nd, 3rd and 4th quartile groups aged 30–64 years and in the 3rd and 4th quartile groups aged 65–74 years. There was no significant interaction between age category and VFA quartile. In the higher weight group, the ORs for the Mets component clustering were significantly higher in the 2nd, 3rd and 4th quartile groups only among participants aged 30–64 years. Conversely, among participants aged 65–74 years, there was no significant association between VFA and Mets. The significant interaction between age category and VFA quartile was observed (p=0.038).
Lifestyle factors and Mets
Table 3 shows the estimated means of VFA according to lifestyle factors. Among normal weight participants, drinking, smoking and exercise habits were significantly associated with VFA in men, and eating quickly was significantly associated with VFA in women. As a result of multiple stepwise regression analysis, independent factors were the same among these lifestyle factors (see online supplementary table S4). As a result of multiple comparisons using the Bonferroni method for smoking habits, the significant difference was observed only between those who quit smoking and those who never smoked in normal weight men. Among higher weight participants, exercise habits and eating until full were significantly associated with VFA in men, and eating until full and eating quickly were significantly associated with VFA in women.
The present study demonstrated that even among normal weight individuals with BMIs 18.5–22.9 kg/m2, dose-dependent responses were observed between VFA and risk of high BP, high FBG, low HDL-C, high TGs and Mets clustering, which are important targets for the prevention of cardiovascular diseases. Among lifestyle factors, currently drinking, poor exercise habit and eating quickly were associated with high VFA.
In a study of Japanese participants with a BMI<25.0 kg/m2 reported by Hiuge-Shimizu et al,12 the mean number of Mets component (elevated BP, dyslipidaemia and abnormal glucose levels) increased with a rise in VFA, and the VFA value by which the mean number of risk factors exceeded one was 100 cm2. These authors suggest that VFA is positively associated with Mets component clustering, which is consistent with our study. However, in the present study, the VFA value that increased the risk was lower than 100 cm2 among normal weight individuals with a BMI 18.5–22.9 kg/m2. Consequently, visceral fat accumulation <100 cm2 may be an important factor for improvement. In addition, among normal weight individuals, the dose-dependent responses between VFA and Mets component clustering were observed in middle-aged individuals and the elderly in the present study. Further studies are needed to confirm the absence of age differences in a large population because the number of elderly subjects was small in the present study.
The present study also demonstrated that dose-dependent responses were observed between VFA and all Mets components among normal weight individuals. At present, the degree of these risks has not been estimated in previous studies.7 ,8 Luo et al,7 investigated Chinese participants with a BMI<25.0 kg/m2 (average 21.7 kg/m2), and reported that the mean levels of total cholesterol, TG, HDL-C and low-density lipoprotein cholesterol significantly increased with a rise in VFA. Miazgowski et al,8 investigated the association between visceral adipose tissue (cm3) and BP, blood glucose and lipid profiles in Caucasian women with an average BMI of 22.2 kg/m2, and reported that visceral adipose tissue significantly correlated with levels of HDL-C and blood glucose, but not TG or BP. The associations between VFA and all Mets components were not consistent among the previous studies. There are several possible explanations for the conflicting results. These previous studies did not involve patients undergoing medical treatment. In the present study, the stronger associations between VFA and Mets might be observed because participants with medical treatment who might have high level of Mets components and VFA were included in the analyses. In addition, differences of distribution by sex, age or ethnic differences among studies might also have influenced the results.
In our study, normal weight men who consumed alcohol, had quit smoking and with poor exercise habits, and women who reported eating quickly had high VFA. For decreasing of VFA to improve Mets, the principal method is lifestyle modification. Although the associations between VFA and lifestyle have become an active area of research during the past decade,26–35 there is no study investigating these factors among normal weight individuals. Although there is no evidence among people with a BMI 18.5–22.9 kg/m2, the present results appear to be accepted because alcohol consumption, quitting smoking, poor exercise habits and eating quickly have been reported to have an association with relatively high energy intake, weight gain and obesity.25 ,36–38 Therefore, modifications for these lifestyle factors may contribute to improve Mets among normal weight individuals.
The present study has several limitations. First, because VFA was not measured by standard diagnostic methods, such as CT scan, we may have missed identifying VFA correctly. VFA estimation by the dual bioelectrical impedance analysis used in the present study can be influenced by body shape or body water distribution.39 However, the dual bioelectrical impedance analysis for measuring VFA is well correlated with that of CT,19 ,20 and we used categorical information of VFA. Therefore, missing VFA classifications might occur less frequently. Second, the participants would have had relatively high health awareness because they voluntarily underwent comprehensive medical check-ups. According to the 2012 National Nutrition Survey in Japan, the percentages of those with a BMI≥25.0 kg/m2 were 29.1% in men and 19.4% in women.40 The participants in the present study had lower percentages, 27.0% in men and 12.3% in women. Therefore, application of the results in the present study to the general population should be carefully considered. Third, the present study had no detailed information including medical treatment and severity of diseases such as liver or renal disease, thyroid disease, tumours or psychiatric diseases which may influence VFA or Mets components. Although the analysis excluding participants who self-reported these diseases was conducted, the influence could not be completely evitable. Fourth, because of the small sample size of former drinkers, these participants were combined with the never drinkers. If the period from quitting alcohol consumption to the time of the health check-ups was short, the difference in the mean VFA might be underestimated. Fifth, because the present study was cross-sectional in design, causality could not be defined. If patients with metabolic risk factors made an effort to reduce their weight by lifestyle modifications, the risks of VFA would be underestimated. Finally, sex-specific risks for metabolic risk factors could not be estimated in the present study because of the small sample size. The risks by sex can be estimated in further studies with large samples.
In conclusions, dose-dependent responses were observed between VFA and risk of high BP, high FBG, high TG and low HDL-C and the clustering of these components among Japanese adults with a BMI<23.0 kg/m2. Further studies are needed to confirm the usefulness of VFA as informative for interventions to improve metabolic risk factors in normal weight people.
We thank all the staff in the Health Check-up Center of the Takeda Hospital Group.
Contributors YT contributed to the conception of the work, performed statistical analysis and drafted the manuscript. YMN contributed to the conception of the work and revising the manuscript critically. IM contributed to the conception of the work and reviewed the manuscript. AH, MT, KN, MW contributed to the interpretation of the result and reviewed the manuscript. TaO and ToO contributed to the interpretation of the result and revising the manuscript critically. YM contributed to the design of the work and the interpretation of the result and reviewed the manuscript. All authors read and approved the final manuscript.
Funding This study was supported by a grant-in-aid for Young Scientists from the Japan Society for the Promotion of Science (15H06913), a grant-in-aid from the Ministry of Health, Labour and Welfare, Health and Labour Sciences research grants, Japan (Comprehensive Research on Cardiovascular Disease, Diabetes and Life-Style Related Diseases: H27–Junkankitou (Seishuu)–Ippan–009), and an Intramural Research Fund (27-4-3) for Cardiovascular Diseases of National Cerebral and Cardiovascular Center.
Competing interests None declared.
Patient consent Obtained.
Ethics approval The study was approved by the Ethics Committee of the National Cerebral and Cardiovascular Center and Takeda Hospital Group (committee approval number: 1404).
Provenance and peer review Not commissioned; externally peer reviewed.
Data sharing statement No additional data are available.